XML 79 R70.htm IDEA: XBRL DOCUMENT v3.21.1
Commitments and Contingencies - Schedule of Supplemental Balance Sheet Information Related to Operating and Financing Leases (Details) - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]    
Operating leases, Right-of-use assets, net [1] $ 3,397 $ 3,397
Operating leases, Right-of-use lease liabilities, current 606  
Operating leases, Right-of-use lease liabilities, noncurrent 3,664  
Total operating lease liabilities 4,270  
Financing Leases, Machinery and equipment, gross 537  
Financing Leases, Accumulated depreciation (226)  
Financing Leases, Machinery and equipment, net 311  
Current liabilities 135  
Noncurrent liabilities 196  
Total financing lease liabilities $ 331  
Weighted average remaining lease term, Operating leases 6 years  
Weighted average remaining lease term, Financing leases 2 years 6 months  
Weighted average discount rate, Operating leases 11.16%  
Weighted average discount rate, Financing leases 11.34%  
[1] Oncocyte recorded certain right-of-use assets and liabilities for operating leases in accordance with ASC 842 (see Notes 5 and 14).